Bill Search

  • Introduced
    Jan 06, 2021
  • Passed Assembly
  • Passed Senate
  • Signed into Law
A 663
New York Assembly Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Last Action See all actions
Assembly • May 19, 2022: PRINT NUMBER 663B
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on A 663

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • May 19, 2022 | Assembly
    • AMEND AND RECOMMIT TO HEALTH
    • PRINT NUMBER 663B
  • May 06, 2022 | Assembly
    • AMEND (T) AND RECOMMIT TO HEALTH
    • PRINT NUMBER 663A
  • Jan 05, 2022 | Assembly
    • REFERRED TO HEALTH
  • Jan 06, 2021 | Assembly
    • REFERRED TO HEALTH
Documents
Looks like we don't have any documents available at this moment.